stoxline Quote Chart Rank Option Currency Glossary
China SXT Pharmaceuticals, Inc. (SXTC)
1.07  -0.03 (-2.73%)    06-17 16:00
Open: 1.11
High: 1.11
Volume: 180,819
Pre. Close: 1.1
Low: 1.05
Market Cap: 1(M)
Technical analysis
2024-06-17 5:26:46 PM
Short term     
Mid term     
Targets 6-month :  1.42 1-year :  1.6
Resists First :  1.21 Second :  1.37
Pivot price 1.09
Supports First :  0.97 Second :  0.8
MAs MA(5) :  1.09 MA(20) :  1.09
MA(100) :  1.51 MA(250) :  2.54
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  29.1 D(3) :  32.2
RSI RSI(14): 45.5
52-week High :  9.37 Low :  0.93
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ SXTC ] has closed above bottom band by 30.3%. Bollinger Bands are 71.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 28 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.11 - 1.12 1.12 - 1.12
Low: 1.04 - 1.04 1.04 - 1.05
Close: 1.06 - 1.07 1.07 - 1.08
Company Description

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.

Headline News

Wed, 17 Apr 2024
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day ... - Markets Insider

Wed, 17 Apr 2024
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket - Markets Insider

Fri, 29 Dec 2023
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Markets Insider

Thu, 05 Oct 2023
China SXT Pharma (NASDAQ: SXTC) to jump 2,500% - a purely technical move - Dhaka Tribune

Wed, 04 Oct 2023
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split - Yahoo Finance

Thu, 07 Sep 2023
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today? - InvestorPlace

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Drug Manufacturers - Specialty & Generic
Shares Out 1 (M)
Shares Float 1 (M)
Held by Insiders 25 (%)
Held by Institutions 0.5 (%)
Shares Short 20 (K)
Shares Short P.Month 64 (K)
Stock Financials
EPS -26.96
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 6.96
Profit Margin 0 %
Operating Margin -995.1 %
Return on Assets (ttm) -45.8 %
Return on Equity (ttm) -141.7 %
Qtrly Rev. Growth -22.3 %
Gross Profit (p.s.) 0
Sales Per Share 1.86
EBITDA (p.s.) -14.47
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio -0.04
PEG Ratio 0
Price to Book value 0.15
Price to Sales 0.57
Price to Cash Flow -8.79
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android